PEN 203

Drug Profile

PEN 203

Alternative Names: Papirine

Latest Information Update: 29 May 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cambrex Corporation; CoPharma
  • Developer CoPharma
  • Class Antivirals
  • Mechanism of Action Immunostimulants; Ribonuclease stimulants; Virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Herpesvirus infections; Human papillomavirus infections

Most Recent Events

  • 30 Sep 1998 A study has been added to the therapeutic trials section
  • 04 May 1998 Phase-II clinical trials for Herpesvirus infections in USA (Topical)
  • 04 May 1998 Phase-II clinical trials for Human papillomavirus infections in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top